Rockefeller Capital Management
CRVS icon

Rockefeller Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Rockefeller Capital Management’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,750
Closed -$1K – 2371
2022
Q4 		$1K Hold
1,750
– – ﹤0.01% 3660
2022
Q3 		$1K Hold
1,750
– – ﹤0.01% 3690
2022
Q2 		$1K Hold
1,750
– – ﹤0.01% 3925
2022
Q1 		$2K Hold
1,750
– – ﹤0.01% 3584
2021
Q4 		$4K Hold
1,750
– – ﹤0.01% 3335
2021
Q3 		$8K Sell
1,750
-750
-30% -$2.22K ﹤0.01% 2979
2021
Q2 		$6K Hold
2,500
– – ﹤0.01% 2961
2021
Q1 		$7K Buy
+2,500
New +$9.03K ﹤0.01% 2736

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return